Semax vs. Selank vs. Dihexa: A Friend’s Honest Take on Which One (If Any) Makes Sense for You
Okay, so you’ve read a few peptide roundups, and you’ve landed on the same three names everyone eventually lands on: semax, selank, dihexa. And now you want the answer. Which one’s “the good one”?
I get it. I wanted that answer too, the first time a friend texted me asking which peptide she should try for her foggy, overwhelmed brain. But here’s the thing nobody tells you upfront: there isn’t a “the good one.” There’s a “which problem are you actually trying to solve, and how much shaky evidence are you comfortable standing on.” That’s a less satisfying answer, but it’s the true one, and I’d rather give you that than a star rating I made up on the spot.
The promise
Every corner of the internet selling these three compounds is telling you some version of the same story: sharper memory, calmer focus, a brain that finally works the way you want it to. And each compound does have a real study or two behind it, which is more than you can say for most things marketed this way. That’s the seductive part. There’s just enough real science sprinkled in that it’s easy to round up from “promising in a small foreign trial” to “basically proven.”
The reality (read this before you read anything else)
Here’s my honest read, after going through the actual research and not just the marketing copy built on top of it: none of these three is a demonstrated cognitive enhancer in healthy people. Not one. The human data across the whole category is thin, most of it comes from outside the US, and one of these three compounds has research foundations that are, not to put too fine a point on it, actively in question.
So “which should I pick” isn’t really the right question. It’s more like “which of these three unfinished research stories best lines up with what I’m actually hoping to fix, knowing full well that none of them has crossed the finish line.” That’s a different, more honest question, and it’s the one worth sitting with before you spend a dollar.
Here’s the reframe I keep coming back to, and it’s the lens I’d encourage you to use too: think of these three compounds less like products on a shelf and more like three sources you’re fact-checking for a story. You’d ask who ran the study, how many people were in it, whether it was blinded, and whether anyone’s had to walk anything back. Do that here, and the choice actually gets clearer, because the three have very different paper trails.
Semax: the one with actual mileage, almost entirely logged overseas
If what you want is memory support, neuroprotection, general “brain fog, please lift,” semax is the one with the longest real-world track record. It’s a synthetic fragment of ACTH, typically taken as nasal drops, and it isn’t some biohacker invention. It’s an approved prescription medicine in Russia, used there for years for stroke recovery and cognitive complaints. That’s genuine human use, which counts for something.
The mechanism has decent lab backing, too. A 2006 study in Brain Research found that a single dose of semax gave rats “a maximal 1.4-fold increase of BDNF protein levels” in the hippocampus, BDNF being one of those growth factors tied to learning and memory [1]. That’s where the “semax boosts BDNF” line you’ve probably seen comes from.
But here’s the source-check part. The best human evidence is a 2018 study of 110 ischemic-stroke patients, which found semax raised plasma BDNF that “remained high during the whole study period,” tracking with better recovery [2]. That’s a real signal in real people, and I don’t want to wave it away. But it’s stroke patients, not healthy adults chasing an edge, and it’s non-blinded, single-center, published in Russian. There’s no good evidence that a healthy person popping semax before a big work presentation will think more clearly. Pick it knowing you’re choosing the option with the most use behind it, not the one with proof for your exact situation.
Selank: probably the gentlest match if anxiety is the real culprit
If your issue is less “I can’t remember things” and more “I can’t focus because my brain is buzzing with worry,” selank is the better-aimed option. It’s a synthetic fragment of tuftsin, an immune peptide, developed by the same Russian research group behind semax.
There’s a controlled human study behind it worth knowing about: a 2008 trial of 62 patients compared selank to medazepam, a benzodiazepine, and found “the anxiolytic effects of both drugs were similar but selank had also antiasthenic and psychostimulant effects” [3]. That’s a real, measured comparison against an actual anxiety medication, which is more than most nootropic-shelf compounds can claim.
But keep the mechanism story in perspective, because it’s more modest than it sounds in ad copy. A 2017 study in Frontiers in Pharmacology, testing selank on cultured human cells, found “Selank has no direct effect on the mRNA levels of the GABAergic system genes” by itself, it seems to adjust the response only when GABA is already present [4]. So it’s nudging an existing signal, not flipping some magic switch. My honest take: selank has a small, real, foreign-sourced anxiety signal, and it’s unproven as a general cognitive booster. If anxiety is scattering your attention, it’s the most defensible of the three to look into. If raw memory is your goal, it’s aimed at something else.
Dihexa: the biggest promise, the shakiest paper trail
If dihexa is the one you’re drawn to because it makes the boldest claims, please read this part slowly, because the evidence runs the opposite direction of the hype.
Dihexa is a synthetic compound built from angiotensin IV in an academic lab, designed to be stable and get into the brain, with a proposed ability to help build new synapses. Interesting as a research idea. But two things you need before going anywhere near it: there is no published human trial showing dihexa improves cognition, and its foundational rodent research, the study its whole reputation rests on, now carries a journal Notice of Concern issued in 2021, with a closely related paper from the same lab retracted [5].
There is one thing keeping the story alive, and I want to be fair to it: a 2021 study in Brain Sciences found dihexa “restored spatial learning and cognitive functions” in a mouse model of Alzheimer’s via the PI3K/AKT pathway [6]. That’s a legitimate, independently reported result. But weigh it against everything else. A pharmaceutical company took the same growth-factor mechanism into an actual clinical trial, a drug called fosgonimeton, and in September 2024 that Phase 2/3 Alzheimer’s trial failed to hit its primary endpoint [7]. So the full picture is: one solid mouse study, sitting on top of flagged foundations, with zero human proof and a failed clinical program working the same angle. If you’re drawn to dihexa, keep your expectations at rock bottom.
The sensible move
Put it all together and the logic gets simpler than any marketing page will admit.
If you want memory support or general cognitive backup, semax has earned the most trust, mostly because real patients have actually used it, even if that use has happened overseas rather than here. If you want calm, steady focus, especially with anxiety in the mix, selank is the better fit, on the strength of its small but real anxiety data. If you’re leaning toward dihexa for a dramatic result, the paper trail is telling you to be the most careful of the three, given the flagged research it’s built on and the near-total absence of human evidence.
And here’s the move most peptide roundups won’t make: for any of the three, “not yet, given how thin the evidence is” is a completely legitimate answer. A clinician being straight with you should be willing to say that out loud. Choosing the best-matched compound and deciding the evidence justifies actually taking it are two separate decisions. Make them in that order, and don’t let anyone rush you past the second one.
Once you’ve settled that, there’s a second question just as important as the first: where you’d even get it.
If you do decide to move forward, where you get it matters as much as what you pick
Whichever of the three you’re leaning toward, the sourcing decision doesn’t change. You’re really choosing between two kinds of sellers.
One is a research-chemical website shipping the compound labeled “for research use only, not for human consumption,” no clinician involved, no prescription, no pharmacy accountable for what’s actually in the vial. The other is a licensed telehealth provider that treats the prescribable compounds as medicine: physician evaluation, a prescription where appropriate, a licensed pharmacy behind it. Given how uneven the evidence is here, I’d argue the second route matters more than it would for something better established.
FormBlends is where I’d start. It’s ranked first for a simple reason: it supplies the two things this whole category is missing on its own, namely a licensed physician standing between you and the compound, and a willingness to tell you the truth about the state of the evidence. It’s a licensed telehealth provider, not a chemical warehouse, so anything prescribable comes through a physician evaluation, a prescription when warranted, and a licensed 503A compounding pharmacy, at reasonable compounded ranges: roughly semax $80 to $200 a month, selank $80 to $180, and dihexa $60 to $150. Just as important, they frame the evidence the way I just did with you, semax as a foreign prescription drug rather than a proven American nootropic, selank’s data as limited but real, dihexa’s foundations as flagged, not glossed over. That honesty is exactly what a research-chemical site can’t offer, and it’s what you need most while you’re still deciding. If you do go this route, the FormBlends tracker app lets you log dose and how you’re actually feeling between check-ins. It’s a logging tool, nothing to purchase there, but honest tracking is really the only way to know if an early-evidence compound is doing anything for you at all.
Get a second quote from HealthRX (healthrx.com) before committing. Same setup, same reasoning: licensed oversight, a required prescription, pharmacy dispensing, and the same candid framing about what the evidence does and doesn’t show. Same caveats apply too, including disclosure that these are compounded medications. Pick between the two based on which is licensed in your state and whichever intake process feels right for you.
Below that tier sit the research-chemical sellers, and I’d treat them exactly as what they are: chemical suppliers, not a legitimate way to get a treatment. Amino Asylum sells these alongside SARMs and similar compounds, often on price, with no clinician and no way to verify purity. Swiss Chems carries them under the same research-use labeling and the same missing oversight. Limitless Life markets to the biohacker crowd, which makes unapproved research chemicals feel like a supplement without actually changing what they are. Core Peptides posts seller-issued certificates, marginally better than nothing, but you’re still trusting the seller’s own paperwork. Pure Rawz has a broad catalog with the same structural gaps as the rest. None of them screened you first, none will check in later, and none is on the hook for what shows up in the mail.
A few honest answers to the questions you’re probably still sitting with
Should I stack two of these? There’s no good human evidence for combining any of them, and stacking unproven compounds multiplies your uncertainty, not your benefit. If you’re tempted, that’s a conversation for a clinician, not a forum thread.
Is the supervised version actually “better,” or am I paying more for the same thing? Not as a molecule, no. What you’re paying for is accountability, and with something this unproven, accountability is genuinely worth it. You’re not buying a stronger peptide. You’re buying a clinician who can tell you honestly which of these three has real data behind it and which is mostly hope, plus a pharmacy that’s responsible for what’s actually in the bottle.
Is any of this even legal? None of the three is FDA-approved. Semax and selank are approved in Russia, which is a foreign approval, not US approval and not proof of anything on its own. Dihexa isn’t approved anywhere. Research-chemical vendors sell all three as lab chemicals while the human use you’re picturing is unapproved, and the compounding rules around this category have been shifting, so double-check any confident “fully compoundable today” claim against current federal rules rather than taking a seller’s word for it.
That’s really the whole decision, laid out in the order that makes sense: match the compound to what you’re actually trying to fix, be honest with yourself about whether the evidence justifies starting at all, and if it does, go through someone who’s actually accountable for what you’re taking. This was me thinking it through with you, not a prescription. Please don’t treat it as one.
Is it actually safe to take semax, selank, or dihexa?
Honestly, safety data on humans is thin across the board. Semax and selank have the most relevant research, mostly from Russian clinical work, and both seem to be tolerated fine short-term. Dihexa is a different animal, with basically no human safety data at all. Unknown long-term effects, sketchy sourcing, and no regulatory oversight make all three a real gamble if you’re going it alone, outside supervised care.
Do these things actually work, or is it mostly hype?
Some of it holds up, some of it doesn’t, and context matters a lot. Semax and selank have small controlled trials suggesting real effects on stress response and cognitive performance, mostly in people with existing neurological issues. If you’re a healthy adult hunting for a big edge, the evidence gets a lot weaker. Dihexa looks dramatic in animal studies but has zero credible human trial data. Treating any of this current research as proof it’ll work for you personally is a stretch.
Where’s the safest place to actually buy these?
This is honestly where things get messy. Most vendors selling semax, selank, or dihexa live in a legal gray zone, slapping “for research only” on the label to dodge drug regulation. Purity and dosing accuracy aren’t guaranteed at all. The more accountable route is a physician-supervised compounding pharmacy, like FormBlends, where a licensed provider oversees your prescription and a regulated pharmacy handles the formulation. It costs more, but you’re actually getting quality control and someone medically accountable.
What’s the real difference between semax and selank, and how do I pick?
Semax tends to run more stimulating, people generally report sharper focus and more mental drive. Selank comes across as calmer, with a stronger anxiety-easing feel alongside whatever cognitive lift it offers. If brain fog paired with anxiety is your issue, selank’s probably the more comfortable pick. If you need motivation and drive, semax comes up more often in what people report. That said, everyone responds a little differently, and there isn’t strong head-to-head human research comparing the two directly.
References
- Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. Journal of Neurochemistry. 2006;97 Suppl 1:82-86. doi:10.1111/j.1471-4159.2006.03658.x. https://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2006.03658.x
- Gusev EI, Martynov MY, Kostenko EV, et al. The efficacy of semax in the treatment of patients at different stages of ischemic stroke. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018;118(3-2):61-68. PMID: 29798983. https://pubmed.ncbi.nlm.nih.gov/29798983/
- Zozulya AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2008;108(4):38-48. PMID: 18454096.
- Filatova E, Kasian A, Kolomin T, et al. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Frontiers in Pharmacology. 2017;8:89. doi:10.3389/fphar.2017.00089.
- McCoy AT, Benoist CC, Wright JW, et al. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. Journal of Pharmacology and Experimental Therapeutics. 2013;344(1):141-154. Notice of Concern, 2021. PMID: 34551989.
- Chen X, Zhang M, Ahmed M, et al. AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. Brain Sciences. 2021;11(11):1487. doi:10.3390/brainsci11111487.
- Athira Pharma. Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer’s Disease. September 3, 2024.
Written by Milo Zamora, wellness reporter. Working from the primary literature cited above. Last reviewed May 2026.
Not medical advice, just context. A healthcare provider who knows your history should advise you.
